308 related articles for article (PubMed ID: 9526094)
21. Intracellular mechanisms of hydrogen peroxide-mediated neutrophil adherence to cultured human endothelial cells.
Okayama N; Coe L; Oshima T; Itoh M; Alexander JS
Microvasc Res; 1999 Mar; 57(2):63-74. PubMed ID: 10049654
[TBL] [Abstract][Full Text] [Related]
22. The role of platelet-activating factor in endothelial cells.
Prescott SM; McIntyre TM; Zimmerman GA
Thromb Haemost; 1990 Aug; 64(1):99-103. PubMed ID: 2274933
[TBL] [Abstract][Full Text] [Related]
23. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
[No Abstract] [Full Text] [Related]
24. The vascular distribution of the platelet-activating factor receptor.
Predescu D; Ihida K; Predescu S; Palade GE
Eur J Cell Biol; 1996 Jan; 69(1):86-98. PubMed ID: 8825027
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.
He J; Bazan HE
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020
[TBL] [Abstract][Full Text] [Related]
26. Platelet activating factor inhibits the expression of matrix metalloproteinases and affects invasiveness and differentiation in a system of human neuroblastoma clones.
Barletta E; Mugnai G; Ruggieri S
Biol Chem; 2002 Jan; 383(1):189-97. PubMed ID: 11928813
[TBL] [Abstract][Full Text] [Related]
27. Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the rat.
Dray F; Gerozissis K; Fafeur V; Wisner A; Bommelaer-Bayet MC; Saadi M; Rougeot C; Tiberghien C; Junier MP
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():383-6. PubMed ID: 2546391
[No Abstract] [Full Text] [Related]
28. Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation.
Dentelli P; Del Sorbo L; Rosso A; Molinar A; Garbarino G; Camussi G; Pegoraro L; Brizzi MF
J Immunol; 1999 Aug; 163(4):2151-9. PubMed ID: 10438956
[TBL] [Abstract][Full Text] [Related]
29. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing.
Ma X; Bazan HE
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1696-702. PubMed ID: 10845588
[TBL] [Abstract][Full Text] [Related]
30. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro.
Cardile V; Mascarucci P; De Simoni MG; Jiang X; Bindoni M
Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980
[TBL] [Abstract][Full Text] [Related]
31. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
[TBL] [Abstract][Full Text] [Related]
32. [Effects of platelet activating factor on blood platelets].
Fu JM
Sheng Li Ke Xue Jin Zhan; 1989 Jan; 20(1):40-4. PubMed ID: 2549618
[No Abstract] [Full Text] [Related]
33. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.
Zimmerman GA; McIntyre TM; Mehra M; Prescott SM
J Cell Biol; 1990 Feb; 110(2):529-40. PubMed ID: 2153685
[TBL] [Abstract][Full Text] [Related]
34. Activation of platelet-activating factor receptor in SZ95 sebocytes results in inflammatory cytokine and prostaglandin E2 production.
Zhang Q; Seltmann H; Zouboulis CC; Travers JB
Exp Dermatol; 2006 Oct; 15(10):769-74. PubMed ID: 16984258
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological modulation of PAF: a therapeutic approach to endotoxin shock.
Sánchez Crespo M; Fernández-Gallardo S
J Lipid Mediat; 1991; 4(2):127-43. PubMed ID: 1659463
[No Abstract] [Full Text] [Related]
36. Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells.
Fragopoulou E; Iatrou C; Antonopoulou S; Ruan XZ; Fernando RL; Powis SH; Moorhead JF; Varghese Z
J Lab Clin Med; 2006 Jun; 147(6):281-9. PubMed ID: 16750665
[TBL] [Abstract][Full Text] [Related]
37. [Platelet-activating factor (PAF) receptor-related pathophysiology].
Ishii S; Shimizu T
Tanpakushitsu Kakusan Koso; 1999 Jun; 44(8 Suppl):1068-74. PubMed ID: 10396985
[No Abstract] [Full Text] [Related]
38. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).
Ferreira MA; Barcelos LS; Teixeira MM; Bakhle YS; Andrade SP
Life Sci; 2007 Jun; 81(3):210-7. PubMed ID: 17588613
[TBL] [Abstract][Full Text] [Related]
39. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis.
Pei Y; Barber LA; Murphy RC; Johnson CA; Kelley SW; Dy LC; Fertel RH; Nguyen TM; Williams DA; Travers JB
J Immunol; 1998 Aug; 161(4):1954-61. PubMed ID: 9712066
[TBL] [Abstract][Full Text] [Related]
40. [Biological role of cellular metabolites--structural analogs of platelet activating factor].
Kulikov VI; Muzia GI
Biokhimiia; 1996 Mar; 61(3):387-403. PubMed ID: 8724598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
